Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Placental ribonuclease inhibitor (PRI) is a member of a family of proteinaceous cytoplasmic RNase inhibitors that occur in many tissues and bind to both intracellular and extracellular RNases (summarized by Lee et al., 1988 [PubMed 3219362]). Additionally we are shipping RNH1 Antibodies (129) and RNH1 Kits (35) and many more products for this protein.
Showing 10 out of 20 products:
Human RNH1 Protein expressed in Wheat germ - ABIN1318405
Rucksaken, Pairojkul, Pinlaor, Khuntikeo, Roytrakul, Selmi, Pinlaor: Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma. in PLoS ONE 2014
Human RNH1 Protein expressed in HEK-293 Cells - ABIN2730897
Ascione, Rowlinson, Avolio, Katare, Meloni, Spencer, Mangialardi, Norris, Kränkel, Spinetti, Emanueli, Madeddu: Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction. in Stem cell research & therapy 2015
Results show that a low expression of RNH1 in metastasis of bladder cancer and suggest that it might regulate the function of ILK through mutual binding.
Data suggest that ribonuclease inhibitor (RNH1) protects HeLa cells from ribonuclease 1 (RNase 1).
a novel mechanism of ANG in regulating PI3K/AKT/mTOR signaling pathway via RI, is reported.
RNH1 bound to RNase 7 and suppressed its antimicrobial activity by blocking its ability to bind the cell wall of uropathogenic bacteria.
angiogenin and ILK signaling pathway plays a pivotal role in mediating the inhibitory effects of RI on melanoma cells growth
RI could play a novel role in inhibiting metastasis of bladder cancer through regulating EMT and ILK signaling pathways.
RNH1 as a regulator of HDACi resistance in gastric cancer
RI might play a novel role in the development of bladder cancer through regulating EMT and the ILK signaling pathway.
PTEN-mediated miR-21 regulation is achieved by inhibiting the interaction between the Drosha complex and RNH1, revealing previously unidentified role of PTEN in the oncogenic miR-21 biogenesis
the anti-tumor effect of RNH1 is also involved in suppressing growth and metastasis
RNH1 (as a recombinant fusion protein) is localized to mitochondria, nuclei, and cytosol in HeLa and HCT cells; RNH1 appears to bind to various mitochondrial proteins.
This protein has been found differentially expressed in the anterior cingulate cortex in men patients with schizophrenia.
Human ribonuclease inhibitor gene has antiangiogenic and antitumor effects when expressed in hematopoietic cells in mouse melanoma models.
Results describe the crystal structure of placental ribonuclease inhibitor in complex with eosinophil-derived neurotoxin, and a mutational analysis based on this structure.
Structural and energetic aspects of the interaction between human RI (hRI) and human pancreatic ribonuclease (RNase 1), is reported.
The conformational and oxidative stabilities of both RIs increase upon complex formation with ribonucleases. Thus, RI has evolved to maintain its inhibition of invading ribonucleases, even when confronted with extreme environmental stress.
This the first measurement of the inhibition of the ribonucleolytic activity of onconase by ribonuclease inhibitor protein.
This protein has been found differentially expressed in the temporal lobe from patients with schizophrenia.
X-ray crystallographic analysis of RNH1 from mouse, bovine and chicken binding to RNase reveals two residues that appear to contribute to the differential binding affinity.
Mouse angiogenin inhibitor 1 interacts with hylA of Streptococcus suis.
Cow placenta ribonuclease inhibitor (CPRI) was isolated, characterized and proved to have radical scavenging activities toward different reactive oxygen species.
Placental ribonuclease inhibitor (PRI) is a member of a family of proteinaceous cytoplasmic RNase inhibitors that occur in many tissues and bind to both intracellular and extracellular RNases (summarized by Lee et al., 1988
placental RNase inhibitor
, placental ribonuclease inhibitor
, ribonuclease inhibitor
, RNase inhibitor
, ribonuclease/angiogenin inhibitor 1
, uncharacterized protein rnh1